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Objective To determine persistence and variability of colonizationwith Pseudomonas aeruginosa in cystic
¢brosis patients over long time periods, and to look for possible cross-colonization.
Methods In total, 469 Pseudomonas aeruginosa isolates were obtained from 30 patients during the period
fromApril 1994 toApril 1996.The sources weremainly sputum and a fewdeep throat swabs. All grown
strains dissimilar inmacromorphologywere processed separately.Typingwith PFGEwas carried out by
contour-clamped homogeneous electric ¢eld electrophoresis. Genomic DNAwas subjected to the rare-
cutting restriction enzyme SpeI. For pyocin typing, the procedure described by Fyfe was applied.
Results After typingwith PFGE, we observed 40 restriction pro¢les. Eighteen di¡erent pyocin types
were found.Themost frequent pyocin typewas type 3, followed by types1and 5.Twenty-two patients
were persistently colonized byone clone speci¢c and di¡erent for each patient, and four were co-colonized
by a second clone also di¡erent for each of these patients. Cross-colonization had apparently been rare in the
cystic ¢brosis center of Leipzig.
Conclusions Typingwith PFGE is well suited for detailed investigations of colonizationwith Pseudomonas
aeruginosa in cystic ¢brosis patients. Pyocin typing can provide additional information for epidemiologic
purposes.
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I N T R O D U C T I O N
The acquisition of Pseudomonas aeruginosa is of great concern
among patients with cystic ¢brosis (CF), as colonization with
P. aeruginosa is responsible for increased morbidity, deteriora-
tion of lung function, and reduced life-expectancy [1].
The means by which this organism is acquired and trans-
mitted are not completely clear. Nevertheless, once P. aerugi-
nosa has taken up residence in the CF respiratory tract, it is
virtually impossible to eradicate it by any regimen of antimi-
crobial chemotherapy [1].
Infection epidemiology has been investigated by means of
several phenotypic [2^6] and, more recently, genetic typing
methods [2,7^18]. Though the new typing methods are very
helpful tools, some epidemiologic information is still contra-
dictory. For example, the heterogeneity of strains among dif-
ferent chronic carriers and their phenotypic and/or genotypic
variability within one individual patient, as well as the roles of
antibiotic therapy and patient-to-patient contact in strain
exchange, are not yet completely understood.
Therefore, in this study this issue was addressed by typing
P. aeruginosa with macrorestriction analysis by PFGE and by
pyocin typing in order to determine the persistence and varia-
bility of the pulmonary colonization and the patient-to-
patient transmission of P. aeruginosa in CF patients of the Leip-
zig area.
M A T E R I A L S A N D ME T H O D S
Patients
The patient population consisted of 30 children, 17 girls and
13 boys, who attended the CF center at the Department of
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Pediatrics at the University of Leipzig between April 1994
and April 1996. Per patient, 2^53 samples (sputum or deep
throat swab specimens) were analyzed (mean value 11.5). The
youngest patient was 4 years old, and the oldest 19 (mean age
13.9 years).The patient group comprised 26 unrelated children
and two pairs of siblings. Most of the patients were hospita-
lized for regular 2-week courses of intravenous chemotherapy
or for treatment of acute exacerbations and were followed up
in the outpatient clinic.
One patient (patient 6) died in this period, and another
one (patient 13) moved away. The patient population com-
prised 28 patients colonized chronically with P. aeruginosa; that
is, P. aeruginosawas detectable in several specimens for at least 6
months. Furthermore, two patients with less than three strains
isolated in the investigation periodwere included in this study,
as they were siblings of two other patients. A synopsis of
patients and isolates is shown inTable1.
Bacteriologic methods
Sputum samples or deep throat swab specimenswere collected
on admission and before discharge from our CF ward and on
outpatient appointments. Isolated strains were assessed by
morphologic features, including pigment production, and
identi¢ed as P. aeruginosa by a positive oxidase reaction and
appropriate results with the API-20 NE system (BioMe¨rieux,
Nu« rtingen, Germany). The strains were stored in special vials
(Microbank, Mast, UK) atÿ20 C. Susceptibility testing was
performed using the disk di¡usion method according to pub-
lished standards [19].
PFGE
PFGE was carried out by contour-clamped homogeneous
electric ¢eld electrophoresis (CHEF-DR III apparatus, Bio-
Rad, Munich) using the Genepath Group 3 Reagent Kit and
the Genepath Gel Kit.The test strains were grown in nutrient
broth overnight at 37 C to a density of 109 cells/mL. Cells
were centrifuged at 11000 rev/min for 2min, and the pellet
was resuspended, mixed with 1.2% agarose and pipetted into
plug molds.The embedded bacteria were incubated with 1mg
of lysozyme for 1h at 37 C and 1mg of proteinase K at 50 C
for 16 h. After four washing steps, restriction digestion was
performedwith the rare-cutting restriction endonuclease SpeI
(25U per plug) for 16 h at 25 C. The digests of the genomic
DNA of P. aeruginosa were separated on 1% agarose gels by
PFGE under the following conditions (program`Psu'): current
range 100^130mA at 14 C for 20 h, initial switch time 5.3 s,
linearly increasing to a ¢nal switch time of 34.9 s, angle 120,
¢eld strength 6V/cm. l ladders were applied as molecular size
markers, size 1018.5^48.5 kb (New England Biolabs, Frank-
furt, Germany).The gels were stained with ethidium bromide
and photographed. Fragment patterns were compared visually
and interpreted by the software RFLPScan (Scanalytics, CSP
Inc., Billerica, MA, USA). Similarity analysis was done with a
database system on the basis of molecular mass patterns [20].
Brie£y, the dendrograms are calculated using theWard algo-
rithm.The distances between gel patterns are calculatedwith a
two-step algorithm. This is a rather heuristic algorithm, but
well tested in a lot of samples. At ¢rst, bands are found that
match within a given range. The range depends on the asso-
ciatedmolecular weight of the band. Bands with higher mole-
cular weights should match better. In the second step, some
optimization is done to improve the match for bands close
together. Each pair of matching bands is weightedwith a coef-
¢cient between 0 (perfect match) and 1 (unmatched).The sum
of all match coe¤cients gives the required distance between
two gel patterns.
Pyocin typing
Pyocin typing was done by the spotting method as described
by Fyfe et al [21].This method is based on the inhibition of 13
P. aeruginosa indicator strains by pyocin produced by the
patients' strains to be typed. The inhibition patterns of eight
indicator strains (set 1^8) describe the main type, and the other
¢ve strains (set A^E) code for the subtype. Thus, 108 main
types and 31subtypes can be identi¢ed.
R ES U L T S
In total, 469 strains from 30 patients were examined. One to
42 strains per patient (mean 15.6) were isolated. The data are
summarized in Table1, together with information on how
long the airways of the individuals had already been colonized
with P. aeruginosa.
PFGE
The DNA digest with SpeI generated between 14 and 25
bands per strain. Forty di¡erent restriction pro¢les were found
and were assigned a number (1^40). Of these clones, 21 had
between two and four clonal variants. Strains were de¢ned as
belonging to the same clone if their restriction patterns were
identical or di¡ered in six or less bands [22]. Identical restric-
tion patterns in di¡erent patients were assigned the same num-
ber. Four strains, all from patient 1, were not typable by
macrorestriction fragment analysis, probably because of high
contents of endogenous nucleases [15].
Pyocin typing
Eighteen di¡erent pyocin types were determined. The most
common pyocin type was type 3 (14 patients), followed by
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Table 1 Results of typing of 469 Pseudomonas aeruginosa strains isolated from 30 patients with cystic ®brosis at the Department of Pedia-
trics, University of Leipzig, Germany (sampling period April 1994 to April 1996)
Patient
number Sex
Age
(years) Colonized since
Total no. of
isolates PFGE pattern
No. of
isolates
No. of clonal
variants Pyocin type
1 F 11 01/1993 12 1
NT
8
4
1
±
6/e(S4,B,E)
6/e(S4,B,E)
2 F 14 06/1992 28 2
3
27
1
4
1
3/e(S7)
2/v
3 F 11 before 1994 26 4
5
25
1
2
1
3/e
31/x
4 F 16 1984 31 6
7
8
24
4
3
2
1
1
1/c, 1/1
5/x(S5)
5/x(S5)
5 F 17 before 1994 16 9 16 2 10/c(S6,7)
6 M 17 1993 27 3
10
18
9
2
2
2/v(S2) (variable)
3/b(S7)
7 M 15 11/1994 11 11 11 1 16/z
8 F 17 before 1994 8 12 8 1 3/e(S5)
9 F 17 before 1994 15 13
14
14
1
3
1
3/e(S2) (variable)
10/b(S6,7)
10 F 16 10/1992 18 15 18 2 3/e, 6/e
11 F 16 04/1991 27 16
17
18
13
13
1
4
4
1
1/p, 1/nt
94/b(SB,E), 101/b(SB,E)
94/b(S4,B,E)
12 M 18 04/1986 28 19 28 3 nt/k, nt/nt
13 F 18 before 1994 3 20 3 2 1/h
14 M 19 1985 11 10 11 1 3/b(S7)
15 F 14 1990 9 21
22
8
1
2
1
3/e(S5)
2/k
16 F 11 11/1994 1 23 1 1 10/c(S6,7)
17 F 9 before 1994 5 24 5 2 3/a(S5,D)
18 M 16 1990 33 25 31 1 3/j, 6/j (variable)
19 F 14 before 1994 15 26
27
14
1
1
1
3/e, 35/e, 5/nt
nt/nt
20 M 7 02/1993 16 28 16 2 nt/y(SA)
21 M 9 1992 30 29 30 2 3/e(S5)
22 F 8 before 1994 42 30
31
32
10
2
1
29/k, 2/k, 5/k, nt/nt (variable)
1/b
23 M 13 1992 6 32 6 2 3/e
24 F 14 03/1994 7 33 7 2 3/e(S5), 3/g
25 F 11 06/1993 4 34 4 1 62/k(S7), 26/k
26 M 15 07/1994 4 35
36
3
1
2
1
nt/k
1/q
27 M 17 11/1992 23 37 23 2 2, 22, 35, 52, 58, nt/nt (variable)
28 M 13 04/1995 6 38 6 1 1/g
29 M 18 1978 5 7
39
40
3
1
1
1
1
1
5/x
19/k
70/nt
30 M 4 01/1996 2 7
40
1
1
1
1
5/x
70/nt
F, female; M, male; NT, not typable with PFGE; nt/nt, no reaction with indicator set 1±8/A-E.
Designation of pyocin typing according to Fyfe et al. [25].
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types 1 (six patients) and 5 (¢ve patients). They were found in
57% of the patients.There was no pyocin activity found with
the indicator set 1^8 in ¢ve patients and with the set A^E in
eight patients. All strains with pyocin de¢ciency were typable
by PFGE.
Patients
Twenty-two patients were persistently colonized by one
clone speci¢c and di¡erent for each patient; in 18 patients,
only one clone was found with PFGE. Four patients (patients
4, 6, 11 and 22; see Table1, Figs 1^3) had two co-colonizing
clones, also di¡erent for each of these patients. In seven
patients, other transiently colonizing clones (i.e. a clone
detected only once or twice in those patients' sputa) were
found; patient 29 harbored two transient clones.
Only three cloneswere isolated frommore than one patient.
Clone 3 was repeatedly found in patient 6 and isolated once
from patient 2 (Table1). Clone 7 was found in patients 4, 29
and 30. Clone 10 was chronically colonizing patients 6 and 14.
Patients sharing identical clones were also found to have iden-
tical pyocin types and antibiograms for the respective strains.
In isolates of individual patients with a stable pyocin type,
PFGE con¢rmed the identity of the isolates, apart from
patients 4 and11. Figure1demonstrates the course of coloniza-
tion in patient 4. This patient constantly harbored clone 6 (24
isolates) and, between July 1994 and April 1995, clone 7 (four
isolates). In August 1995, another strain emerged (three iso-
lates) with a PFGE pattern di¡ering in more than six bands
from clone 7, andwas assigned a separate PFGE number (clone
8). The antibiotic susceptibility changed from sensitive (clone
7) to resistant to azlocillin, piperacillin, and ceftazidime (clone
8). However, colony morphology and pyocin type were iden-
Figure 1 PFGE patterns of 31 strains from patient 4. The patient harbors three clones: clone 7 (lanes 2, 6, 9, and 16), clone 8 (lanes
2, 3, 28, and 31), and clone 6 with two clonal variants (the remaining lanes). Strains 23, 28 and 31 differ in more than six bands
from strains 2, 6, 9 and 16, and therefore were assigned a separate PFGE number. Clones 7 and 8 show the same pyocintype 5/
x(S5), and clone 6 has pyocintype 1. l is the molecular size marker (PFG Marker, New England Biolabs, 50±100 kb). See also Figure
2.
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tical for both clones. In patient 11, altogether 14 strains were
found with the similar pyocin types 94/b and 101/b, 13 of
which belonged to clone17.One strain, however, gave a di¡er-
ent pattern (clone 18) and a di¡erent antibiogram.This patient
was colonized by two unrelated clones with several clonal var-
iants. Besides the above mentioned clones 17 and 18, 13 strains
belonged to clone16 (Table 2).
We also typed strains isolated from two pairs of siblings.
Patients 29 (aged 18) and 30 (aged 4) are brothers. Both
attended our CF center until 1992 and again at the end of 1995
and had no contact with the other patients in between.
Among the ¢ve isolates of patient 29, three di¡erent clones
were identi¢ed: clones 7, 39 and 40. Patient 30 harbored clones
7 and 40 (Figure 3 andTable 3). However, this patient was only
sampled twice, and thus a conclusion about the persistence of
these strains cannot be drawn. Patients 16 and 17 are sisters.
Patient 17 carried ¢ve strains of clone 24. In patient 16, chronic
colonization had not yet occurred and only one strainwas iso-
lated, giving a fragment pattern di¡erent from that of her sis-
ter (clone 23). Identical isolates of one clone often displayed a
variable pyocin type (e.g. patients 6, 9, 18, 19 and 22). Usually,
there was no relationship between minor changes in pyocin
type and the appearance of clonal variants. Also, the appear-
ance of clonal variants with alterations in only a few bands had
as a rule no in£uence on pyocin pattern, antibiotic susceptibil-
ity, or colony morphology. For the majority of strains with
similar pyocin type, PFGE revealed the genetic diversity of the
strains (Table 4).
D IS C U S S IO N
Recent research has shown that the initial colonizing strain
remains dominant in the CF lung. Ro« mling et al [15] studied
three sisters and nine unrelated patients over a period of 8
years, using macrorestriction analysis with PFGE. The initi-
ally acquired strain persisted over the whole study period;
only two patients lost their clone after 3 years. Horrevorts et al
[3] monitored15 CF patients over periods up to 5 years, apply-
ing serotyping, phage typing, and pyocin typing.They found
that, generally, one serotype predominated and that the colo-
nization with P. aeruginosawas quite constant. Mahenthiralin-
gam et al [13] typed 385 isolates from 20 CF patients by
Figure 2 Dendrogram of similarities of 31 fragment patterns
from patient 4. Strain numbers correspond with lanes in Fig-
ure 3. The patient is co-colonized by strains of two major clus-
ters. The upper cluster is formed by clones 6A and 6B. The
lower cluster represents clones 7 and 8. The similarity analysis
suggests clonal relatedness between clones 7 and 8, despite
differences in more than four bands.
Figure 3 PFGE patterns of ®ve P. aeruginosa isolates from
patient 29 (lanes 1±5) and two isolates from his brother,
patient 30 (lanes 6 and 7). The typing results for the strains are
summarized in Table 1. l is the molecular size marker (PFG
marker, New England Biolabs, 50±100 kb).
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random ampli¢ed polymorphic DNA (RAPD)-PCR. The
observation period varied from 1 to over 10 years per patient.
The authors found a strain replacement in four patients, and
four other patients were co-infected with two or more clones.
The replacing strains showed new RAPD ¢ngerprints. Our
results basically support these ¢ndings. In this study, macro-
restriction analysis reliably revealed the identity or high simi-
larity of isolates from a given patient as well as distinct
di¡erences in the case of co-colonization by two or more
clones. In contrast to other studies [1,18], however, we could
not show a strain loss or turnover. It should be kept in mind
that the situation in CF patients who receive regular antimi-
crobial treatment over many years may not re£ect the natural
course of infection in the CF respiratory tract [9]. Intensive
antimicrobial therapymight well lead to a signi¢cant selection
of optimally adapted P. aeruginosa strains.
In patient 4, we observed a loss of more than four restriction
fragments in a strain chronically colonizing this patient. The
emergence of this altered strain was accompanied by an
obvious change in the antibiotic susceptibility pattern. Inter-
estingly, the pyocin type and colony morphology remained
stable. Further investigations are necessary to make clear
whether an association between the loss of restriction frag-
ments and change in antibiotic susceptibility exists. The
assumption of a genetic relatedness rather than a strain replace-
ment was supported by the unchanged pyocin type. Here,
PFGE together with pyocin typing has provided valuable epi-
demiologic information, which would be not possible using
either a genetic or a phenotypic method.
Several epidemiologic studies have addressed the question
of cross-infection between unrelated patients [2,11,15,17,18]
and siblings [2,11,15]. It has been shown that P. aeruginosa
Table 2 Comparison of pyocin types and fragment patterns from 27 P. aeruginosa strains isolated from patient 11
Strain Date of isolation Colony Pyocin type PFGE pattern
Antibiogram
PIP CAZ IMP GEN CIP AZL
1 26/04/94 nm 1/k 16A r r s r s r
3 12/08/94 nm 1/p 16A r s s r s r
5 29/08/94 nm 1/u 16C r r s r s r
6 08/09/94 nm 1/p 16A r i s r i r
8 16/09/94 nm 1/nt 16B r r s r s r
9 07/10/94 nm 1/p 16A r i s r s r
10 23/11/94 nm 1/nt 16B r s s r s r
12 17/01/95 nm 1/nt 16C r i s r r r
13 07/02/95 nm 1/nt 16A r s s r s r
16 28/03/95 nm 1/nt 16C r s s r s r
23 17/11/95 nm 1/nt 16A r i i r s r
25 24/01/96 nm 1/g 16D r r r s r r
27 06/02/96 nm 1/g 16D r r s r r r
11 17/01/95 m 94/b(SB,E) 17A s s nd s nd s
14 15/02/95 m 94/b(SB,E) 17A s s s s s s
15 28/03/95 m 94/b(SB,E) 17A s s s s s s
17 20/06/95 m 94/b(SB) 17A s s s s s s
18 20/07/95 m 94/b(SB,E) 17A s s s s s s
19 05/10/95 m 94/g(SA,B,E) 17A s s s s s s
21 06/11/95 m 94/g(SA,B) 17A s s s s s s
24 24/01/96 m 94/b 17C r s s r s r
26 06/02/96 m 94/b(SB) 17A s s i s s s
2 12/07/94 nm 94/b(S4,B,E) 18 r r s r s r
4 12/08/94 m 101/b(S4,B,E) 17A ND ND ND ND ND ND
7 16/09/94 nm 101/b(SB) 17D s s r s s s
20 05/10/95 m 101/b(SB,E) 17B s s s s s s
22 17/11/95 m 101/g(SA,B) 17B s s s s s s
Both typing methods detected two major clones over the whole sampling period. There is no relation between clonal variants of one clone
and minor changes in pyocin pattern or antibiogram. Strain 2 differs in more than six bands from the other clones; however, pyocin typing
suggests that it belongs to clone 17. m, mucoid; nm, not mucoid; s, susceptible; i, intermediate; r, resistant; PIP, piperacillin; CAZ,
ceftazidime; IMP, imipenem; GEN, gentamicin; CIP, cipro¯oxacin; AZL, azlocillin; ND, not done; nt, no reaction with indicator set A±E; 16A-D
and 17A-D, clonal variants of genotypes 16 and 17.
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spreads among a¡ected children of a family, as the contact is
close and/or prolonged.We included a male and a female sib-
ling pair in our study. The elder brother harbored three dis-
tinct clones, of which one was found on three sampling
occasions and seemed to predominate. The younger brother
was colonized by the predominating and another clone of the
elder brother.The two sisters did not share the same clone.
Only three clones were found in more than one patient.
Patients 6 and 14 harbored an identical clone over the whole
study period.Whether the strain was passed from one patient
to the other or whether it was contracted from a common
environmental source remains unclear. From patient 2, a clone
was isolatedwhich persistently colonized patient 6. On the day
of isolation, both patients were hospitalized on di¡erent
wards. Patient 6 was critically ill and admitted to the ICU, so
cross-colonization could have taken place only during a visit
by patient 2. Patients 4, 29 and 30 attended our center in di¡er-
ent months and thus were unable to directly co-infect each
other during the study period.
The results indicate that cross-colonization is rare in our
CF center, which might be explained by the segregation of
infected and non-infected patients and patients with multiply
resistant strains. Furthermore, the results correlate well with
the ¢ndings of other investigators, indicating remarkable
genetic heterogeneity among P. aeruginosa strains colonizing
the patient population of the CF center of Leipzig
[13,14,16,18].
Summarizing our results, the typing of restriction fragment
patterns of P. aeruginosa strainswith PFGE combined high typ-
ability and discriminatory capacity. Under selected condi-
tions, pyocintyping can provide interesting additional
information.The surveillance of patients regularly attending a
CF center may form a valuable part of a hygienic quality con-
trol program considering measures against cross-coloniza-
tion.
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